<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">68812</article-id><article-id pub-id-type="doi">10.7554/eLife.68812</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Epidemiology and Global Health</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Impact of asymptomatic <italic>Plasmodium falciparum</italic> infection on the risk of subsequent symptomatic malaria in a longitudinal cohort in Kenya</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-233136"><name><surname>Sumner</surname><given-names>Kelsey M</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-233137"><name><surname>Mangeni</surname><given-names>Judith N</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-233138"><name><surname>Obala</surname><given-names>Andrew A</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-233139"><name><surname>Freedman</surname><given-names>Elizabeth</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-233140"><name><surname>Abel</surname><given-names>Lucy</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-233141"><name><surname>Meshnick</surname><given-names>Steven R</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-233142"><name><surname>Edwards</surname><given-names>Jessie K</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-233143"><name><surname>Pence</surname><given-names>Brian W</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-233144"><name><surname>Prudhomme-O'Meara</surname><given-names>Wendy</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-8932"><name><surname>Taylor</surname><given-names>Steve M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2783-0990</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Epidemiology</institution>, <institution>UNC Gillings School of Global Public Health</institution>, <addr-line><named-content content-type="city">Chapel Hill</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">School of Public Health</institution>, <institution>Moi University</institution>, <addr-line><named-content content-type="city">Eldoret</named-content></addr-line>, <country>Kenya</country></aff><aff id="aff3"><institution content-type="dept">School of Medicine</institution>, <institution>Moi University</institution>, <addr-line><named-content content-type="city">Eldoret</named-content></addr-line>, <country>Kenya</country></aff><aff id="aff4"><institution content-type="dept">Medicine</institution>, <institution>Duke University Medical Center</institution>, <addr-line><named-content content-type="city">Durham</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution content-type="dept">AMPATH</institution>, <institution>Moi Teaching and Referral Hospital</institution>, <addr-line><named-content content-type="city">Eldoret</named-content></addr-line>, <country>Kenya</country></aff><aff id="aff6"><institution content-type="dept">Medicine</institution>, <institution>Duke University School of Medicine</institution>, <addr-line><named-content content-type="city">Durham</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-200959"><name><surname>Ferreira</surname><given-names>Marcelo U</given-names></name><role>Reviewing editor</role><aff><institution>University of São Paulo</institution>, <country>Brazil</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>steve.taylor@duke.edu</email> (ST);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>23</day><month>07</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e68812</elocation-id><history><date date-type="received"><day>26</day><month>03</month><year>2021</year></date><date date-type="accepted"><day>20</day><month>07</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Sumner et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Sumner et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-68812-v1.pdf"/><abstract><p><bold>Background:</bold>Asymptomatic <italic>Plasmodium falciparum</italic> infections are common in sub-Saharan Africa, but their effect on subsequent symptomaticity is incompletely understood.</p><p><bold>Methods:</bold>In a 29-month cohort of 268 people in Western Kenya, we investigated the association between asymptomatic <italic>P. falciparum</italic> and subsequent symptomatic malaria with frailty Cox models.</p><p><bold>Results:</bold>Compared to being uninfected, asymptomatic infections were associated with an increased 1-month likelihood of symptomatic malaria [adjusted Hazard Ratio (aHR):2.61, 95%CI:2.05-3.33], and this association was modified by sex, with females [aHR:3.71, 95%CI:2.62-5.24] at higher risk for symptomaticity than males [aHR:1.76, 95%CI:1.24-2.50]. This increased symptomatic malaria risk was observed for asymptomatic infections of all densities and in people of all ages. Long-term risk was attenuated but still present in children under 5 [29-month aHR:1.38, 95%CI:1.05-1.81].</p><p><bold>Conclusions:</bold>In this high-transmission setting, asymptomatic <italic>P. falciparum</italic> can be quickly followed by symptoms and may be targeted to reduce the incidence of symptomatic illness.</p><p><bold>Funding:</bold>This work was supported by the National Institute of Allergy and Infectious Diseases (R21AI126024 to WPO, R01AI146849 to WPO and SMT).</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>P. falciparum</italic></kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>R21AI126024</award-id><principal-award-recipient><name><surname>Prudhomme-O'Meara</surname><given-names>Wendy</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>R01AI146849</award-id><principal-award-recipient><name><surname>Prudhomme-O'Meara</surname><given-names>Wendy</given-names></name><name><surname>Taylor</surname><given-names>Steve M</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: The study was approved by institutional review boards of Moi University (2017/36), Duke University (Pro00082000), and the University of North Carolina at Chapel Hill (19-1273). All participants or guardians provided written informed consent, and those over age 8 provided additional assent.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Data will be shared under the auspices of the Principal Investigators. Investigators and potential collaborators interested in the datasets will be asked to submit a brief concept note and analysis plan. Requests will be vetted by Drs. O'Meara and Taylor and appropriate datasets will be provided through a password protected secure FTPS link. No personal identifying information will be made available to any investigator. Relevant GPS coordinates would only be provided when 1) the planned analysis cannot reasonably be accomplished without them and 2) the release of the coordinates is approved by the Institutional Review Board. A random error in the latitude and longitude of 50-100 meters will be added to each pair of coordinates to protect individual household identities. General de-identified datasets will be prepared that can accommodate the majority of requests. These will be prepared, with documentation, as the data is cleaned for analysis in order to reduce time and resources required to respond to individual requests. Recipients of study data will be asked to sign a data sharing agreement that specifies what the data may be used for (specific analyses), criteria for acknowledging the source of the data, and the conditions for publication. It will also stipulate that the recipient may not share the data with other investigators. Requests for data use must be made directly to the PI and not through third parties.</p></sec><supplementary-material><ext-link xlink:href="elife-68812-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>